Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

ARS Pharmaceuticals, Inc.

SPRY · Nasdaq · CIK 0001671858 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

3 Form 4 transaction lines observed in the same window
2 sales · 1 option, withholding, award, gift or other lines

Last qualifying purchase2024-03-27 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. · $5.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Karas EricChief Commercial Officer
○▼
Fitzpatrick Alexander AChief Legal Officer
▼
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-03-27 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M..

Recent Form 4 activity

0Purchases
5Sales
5Other Form 4 lines
5SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER1 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
21,190,047
Previous report
23,073,209
Avg daily volume
1,316,280
Days to cover
16.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-03-27Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.Purchase (P)Common Stock505,954USD 9.79USD 4,953,290SEC filing ↗
2024-03-26Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.Purchase (P)Common Stock457,745USD 9.55USD 4,371,465SEC filing ↗
2024-03-25Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.Purchase (P)Common Stock437,600USD 9.06USD 3,964,656SEC filing ↗
2023-09-29Fitzpatrick Alexander APurchase (P)Common Stock46,258USD 3.78USD 174,855SEC filing ↗
2023-09-28Fitzpatrick Alexander APurchase (P)Common Stock40,000USD 3.62USD 144,800SEC filing ↗
2023-09-21Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.Purchase (P)Common Stock2,700,000USD 3.03USD 8,183,526SEC filing ↗
2023-08-29Thompson Peter A.Purchase (P)Common Stock500,000USD 6.20USD 3,100,000SEC filing ↗
2023-08-29ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP VI LLCPurchase (P)Common Stock500,000USD 6.20USD 3,100,000SEC filing ↗
2023-08-29Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.Purchase (P)Common Stock3,750,000USD 6.20USD 23,250,000SEC filing ↗
2022-11-29Scott Kathleen D.Purchase (P)Common Stock8,250USD 6.24USD 51,480SEC filing ↗
2021-11-15ROOT JONATHAN DPurchase (P)Common Stock2,014USD 8.85USD 17,824SEC filing ↗
2021-03-03ROOT JONATHAN DPurchase (P)Common Stock350USD 52.07USD 18,224SEC filing ↗
2020-12-08Hawkinson RussPurchase (P)Common Stock200USD 21.00USD 4,200SEC filing ↗
2020-12-08Thompson Peter A.Purchase (P)Common Stock1,190,477USD 21.00USD 25,000,017SEC filing ↗
2020-12-08Schroeder ThiloPurchase (P)Common Stock238,096USD 21.00USD 5,000,016SEC filing ↗

Form 4 evidence

10 transaction lines in the latest 365-day window; 341 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-12Karas EricSale (S)Common Stock25,000USD 10.00USD 250,000SEC filing ↗
2026-06-12Karas EricOption exercise / conversion (M)Common Stock25,000USD 1.50USD 37,500SEC filing ↗
2026-06-12Fitzpatrick Alexander ASale (S)Common Stock3,355USD 10.00USD 33,550SEC filing ↗
Show recent Form 4 evidence (8 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-12Karas EricSale (S)Common Stock25,000USD 10.00USD 250,000SEC filing ↗
2026-06-12Karas EricOption exercise / conversion (M)Common Stock25,000USD 1.50USD 37,500SEC filing ↗
2026-06-12Fitzpatrick Alexander ASale (S)Common Stock3,355USD 10.00USD 33,550SEC filing ↗
2025-11-13Dorsey BrianSale (S)Common Stock21,828USD 8.71USD 190,122SEC filing ↗
2025-11-13Dorsey BrianOption exercise / conversion (M)Common Stock21,828USD 0.64USD 13,970SEC filing ↗
2025-11-12Shah PratikGift (G)Common Stock350,000USD 0.00USD 0SEC filing ↗
2025-11-12Chakma JustinSale (S)Common Stock166,380USD 8.87USD 1,475,627SEC filing ↗
2025-11-12Chakma JustinOption exercise / conversion (M)Common Stock30,000USD 0.84USD 25,200SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerSPRY
CIK0001671858
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history341 transaction lines from 2020-12-08 to 2026-06-12
24 P purchase lines · 199 S sale lines · 118 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.